/> /> /> /> /> /> />

ABBVIE INC (ABBV) Stock Forecast & Price Prediction

Data as of · ABBV trades at $266.16 (+1.12% today) · Health Care sector.

ML Forecast (5-day)

42% bearish

Probability of beating the S&P 500 over 5 trading days

Q-Score

55/100

Grade C — "Hold" composite of 140+ signals

Analyst Target

$278.65

100 targets · $276.29–$282.56 · implied +4.7%

Next Earnings

2026-07-30

in 0 days — expect volatility

Why the model says this

The ML model scores ABBV on 51 live features, trained on 5,328 labeled outcomes and walk-forward validated. Biggest drivers of today's bearish call:

Pushing the forecast up

  • Yield Curve Spread +0.041
  • Price Vs52w High +0.011
  • Housing Starts Roc +0.009
  • Bollinger Percent B +0.008
  • Sma200 Distance +0.008

Pushing it down

  • M2 Money Supply Yoy -0.017
  • Atr Ratio -0.009
  • Piotroski FScore X Trailing PE -0.008
  • Sector Momentum Rank -0.007
  • Price To Book -0.007

What Wall Street is saying about ABBV

Across 100 price targets published in the last 90 days (latest 2026-07-29), the consensus for ABBVIE INC is $278.65 — spanning $276.29 on the low end to $282.56 on the high end.

Next-period consensus: EPS n/a (as of 2030-12-31).

Track record — don't trust a forecast without one

StoQuant publishes its full walk-forward accuracy, updated daily. Current hit rates across all scored signals:

SignalWindowHit rateAvg returnObservations
Fundamental Undervalue7d51.6%+0.52%8,963
Vc Intelligence7d50.0%+0.60%16
Insider Buying7d49.4%+0.66%1,052
Volume Spike7d49.4%+0.25%6,072

See the full live track record → · How the model works

⚠ ABBVIE INC reports earnings on 2026-07-30 — expect elevated volatility and a forecast refresh right after the report.

Peers & alternatives

AZN researchNVS researchNVO researchSNY researchGSK research

Compare ABBV vs AZN head-to-head →

ABBV forecast FAQ

What is the ABBV stock forecast?

StoQuant's ML model estimates a 42% probability that ABBVIE INC (ABBV) outperforms the S&P 500 over the next 5 trading days — a bearish short-term signal. Wall Street's consensus 12-month price target is $278.65 from 100 analyst targets.

Is ABBV stock a buy or sell right now?

StoQuant's Q-Score rates ABBV 55/100 (grade C, "Hold") and the 5-day ML signal is bearish at 42% probability. StoQuant publishes its full walk-forward track record at /proof — always check a forecaster's accuracy before acting.

What is the analyst price target for ABBV?

The consensus analyst price target for ABBVIE INC is $278.65, with a range of $276.29 to $282.56 across 100 recent analyst targets — an implied +4.7% move from the current price of $266.16.

How accurate are StoQuant's stock forecasts?

Across StoQuant's walk-forward validated signal history, the fundamental undervalue signal hit its 7-day target in 51.6% of 8,963 observations (avg return +0.52%). Full methodology and live accuracy at /proof.

When does ABBV report earnings?

ABBVIE INC is scheduled to report earnings on 2026-07-30. Expect elevated forecast volatility around the report.

Get ABBV's forecast refreshed daily — plus the full signal stack.

ML forecasts, Q-Scores, insider clusters, and catalysts across 4,000+ tickers. Free screener.

Open the free screener Full ABBV research

Forecasts are probabilistic model outputs, not investment advice. Past accuracy does not guarantee future results. Methodology.